Artificial Intelligence and Machine Learning for Safe Medicines

Andrew Bate () and Yuan Luo
Additional contact information
Andrew Bate: GSK
Yuan Luo: Northwestern University

Drug Safety, 2022, vol. 45, issue 5, No 1, 403-405

Abstract: Authors’ views on the role of artificial intelligence and machine learning in pharmacovigilance. (MP4 139807 kb)

Date: 2022
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40264-022-01177-0 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:45:y:2022:i:5:d:10.1007_s40264-022-01177-0

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/s40264-022-01177-0

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().